Freja Herborg

发表

A dominant-negative variant in the dopamine transporter PDZ-binding motif is linked to parkinsonism and neuropsychiatric disease

T. Werge, A. Galli, A. Newman, 2020 .

Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals

M. Parent, L. Trudeau, U. Gether, 2020, bioRxiv.

Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors

U. Gether, Tommaso Patriarchi, Lin Tian, 2022, Communications Biology.

Nanoscopic dopamine transporter distribution and conformation are inversely regulated by excitatory drive and D2 autoreceptor activity

M. Sauer, A. Newman, U. Gether, 2022, bioRxiv.

A density-based enrichment measure for assessing colocalization in single-molecule localization microscopy data

U. Gether, K. Madsen, Freja Herborg, 2022, Nature Communications.

Behavioral encoding across timescales by region-specific dopamine dynamics

Jakob K. Dreyer, U. Gether, A. T. Sørensen, 2022, bioRxiv.

Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.

M. Wallace, Heinrich J.G. Matthies, A. Galli, 2019, The Journal of clinical investigation.

Neuropsychiatric disease–associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes

Thorvald F. Andreassen, U. Gether, C. Loland, 2018, The Journal of Biological Chemistry.

Disruption of the PDZ domain–binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation

R. Gainetdinov, A. Fink-Jensen, G. Wörtwein, 2021, The Journal of biological chemistry.

Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors

U. Gether, Tommaso Patriarchi, Lin Tian, 2021, Communications Biology.

Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease

T. Werge, A. Galli, A. Newman, 2021, JCI insight.

Disrupted PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation

R. Gainetdinov, A. Fink-Jensen, G. Wörtwein, 2021, bioRxiv.

Dopaminergic neurons establish a distinctive axonal arbor with a majority of non‐synaptic terminals

M. Parent, L. Trudeau, U. Gether, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Structural basis of organic cation transporter-3 inhibition

T. Werge, H. Sitte, T. Stockner, 2022, bioRxiv.

Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout

B. Giros, L. Trudeau, U. Gether, 2019, PLoS genetics.

Relative enrichment – a density-based colocalization measure for single-molecule localization microscopy

U. Gether, K. Madsen, Freja Herborg, 2022, bioRxiv.

Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca2.

U. Gether, Freja Herborg, J. F. Støier, 2023, The Journal of biological chemistry.

Constitutive internalization across therapeutically targeted GPCRs correlates with constitutive activity

K. Madsen, Freja Herborg, Jan H. Schmidt, 2020, Basic & clinical pharmacology & toxicology.

Disruptive mutations in the serotonin transporter associate serotonin dysfunction with treatment-resistant affective disorder

T. Werge, R. Blakely, H. Rasmussen, 2023, medRxiv.

Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.

M. Wallace, Heinrich J.G. Matthies, A. Galli, 2019, The Journal of clinical investigation.

Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and psychiatric disease

B. Holst, L. Trudeau, U. Gether, 2023, bioRxiv.